Get the full Hospital-Acquired Infections public health report
The full report covers burden, affected groups, risk factors, screening, treatment coverage, programmes, gaps and outlook, with a source and year for every figure.
| Place | Active trials | Report |
|---|---|---|
| World | 47 | View report |
 Bangladesh | 0 | View report |
 Egypt | 1 | View report |
 India | 1 | View report |
 Indonesia | 0 | View report |
 Kenya | 1 | View report |
 Nigeria | 0 | View report |
 Pakistan | 0 | View report |
Public clinical research
47 active trials found worldwide on ClinicalTrials.gov.
See the public searchLatest public research
- How to Adequately Treat Pseudomonas aeruginosa Infections.Seminars in respiratory and critical care medicine, 2026
- Analysis of the etiology of infection and antimicrobial resistance in chronic critically ill patients: a longitudinal study.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures), 2026
- Phenotypic Characterization of Clindamycin Resistance in Methicillin-resistant Staphylococcus aureus: Implications for Clinical Therapy.Annals of African medicine, 2026
- Multidrug resistance and clinical outcomes among patients with confirmed Enterococcus infections in a tertiary hospital in a low- and middle-income setting.BMC infectious diseases, 2026
- Targeted vs Standard Contact Precautions and Transmission of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in Critically Ill Adults: A Pilot Clinical Trial.CHEST critical care, 2026
Public trial and paper counts come from ClinicalTrials.gov and PubMed. Acuitas market figures are not published on this page.